Gao Rui, Liu Mingyi, Chen Yu, Xia Chunhua, Zhang Hong, Xiong Yuqing, Huang Shibo
Clinical Pharmacology Institute, Nanchang University, Nanchang, 330006, PR China; Peking University Binhai Hospital (Tianjin Fifth Center Hospital), Tianjin, 300450, PR China.
Clinical Pharmacology Institute, Nanchang University, Nanchang, 330006, PR China.
Drug Metab Pharmacokinet. 2016 Aug;31(4):261-8. doi: 10.1016/j.dmpk.2015.11.010. Epub 2015 Dec 17.
This study aims to characterize the glucuronidation kinetics of ursolic acid (UA) in human liver microsomes (HLMs) and intestinal microsomes (HIMs) and identify the main UDP-glucuronosyltransferases (UGTs) involved. In our present study, only one type of UA glucuronide was observed after incubation with HLMs and HIMs respectively and was identified as a UA hydroxyl O-glucuronide. The glucuronidation of UA can be shown in HLMs and HIMs with Km values of 3.29 ± 0.16 and 3.74 ± 0.22 μM and Vmax values of 0.33 ± 0.03 and 0.42 ± 0.03 nmol/min/(mg protein). Among the 12 recombinant UGT enzymes investigated, UGT1A3 and UGT1A4 were identified as the major enzymes catalyzing the glucuronidation of UA [Km values of 2.58 ± 0.12 and 4.66 ± 0.60 μM, Vmax values of 0.72 ± 0.01 and 1.00 ± 0.06 nmol/min/(mg protein)]. The chemical inhibition study showed that the IC50 for hecogenin inhibition of UA glucuronidation was 51.79 ± 4.32 μM in HLMs. And chenodeoxycholic acid inhibited UA glucuronidation in HLMs with an IC50 of 28.26 ± 2.91 μM. In addition, UA glucuronidation in a panel of eight HLM was significantly correlated with telmisartan glucuronidation (r(2) = 0.7660, p < 0.01) and trifluoperazine glucuronidation (r(2) = 0.5866, p < 0.01) respectively. These findings collectively indicate that UGT1A3 and UGT1A4 were the main enzymes responsible for the glucuronidation of UA in human.
本研究旨在表征熊果酸(UA)在人肝微粒体(HLMs)和小肠微粒体(HIMs)中的葡萄糖醛酸化动力学,并确定主要参与的尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)。在我们目前的研究中,分别与HLMs和HIMs孵育后仅观察到一种类型的UA葡萄糖醛酸化物,并被鉴定为UA羟基O - 葡萄糖醛酸化物。UA在HLMs和HIMs中的葡萄糖醛酸化表现为,Km值分别为3.29±0.16和3.74±0.22μM,Vmax值分别为0.33±0.03和0.42±0.03 nmol/min/(mg蛋白质)。在所研究的12种重组UGT酶中,UGT1A3和UGT1A4被鉴定为催化UA葡萄糖醛酸化的主要酶[Km值分别为2.58±0.12和4.66±0.60μM,Vmax值分别为0.72±0.01和1.00±0.06 nmol/min/(mg蛋白质)]。化学抑制研究表明,在HLMs中,海柯皂苷元抑制UA葡萄糖醛酸化的IC50为51.79±4.32μM。鹅去氧胆酸在HLMs中抑制UA葡萄糖醛酸化,IC50为28.26±2.91μM。此外,一组8种HLM中UA的葡萄糖醛酸化分别与替米沙坦的葡萄糖醛酸化(r(2)=0.7660,p<0.01)和三氟拉嗪的葡萄糖醛酸化(r(2)=0.5866,p<0.01)显著相关。这些发现共同表明,UGT1A3和UGT1A4是人体内负责UA葡萄糖醛酸化的主要酶。